Lv71
4960 积分 2021-07-09 加入
Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections
2天前
已完结
Advancing familial hypercholesterolaemia management: real-world evidence for inclisiran's impact on LDL-C and arterial stiffness
9天前
已完结
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
16天前
已完结
Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality
1个月前
已完结
Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality
1个月前
已完结
Late-onset Carbapenem-resistant Enterobacteriaceae Sepsis Among Very Preterm Infants: A Multicenter Study in China
1个月前
已完结
AAUS guideline for acute uncomplicated pyelonephritis
1个月前
已完结
Incidence of community-acquired pneumonia in urban China: A national population-based study
1个月前
已完结
皖公网安备34019202002308
